E-prescribing platforms market seen reaching $12.02 billion by 2030

By AI, Created 4:51 PM UTC, May 18, 2026, /AGP/ – The global e-prescribing platforms market is projected to nearly triple from $4.8 billion in 2026 to $12.02 billion by 2030, according to The Business Research Company. Growth is being driven by electronic health record adoption, telemedicine, cloud systems and tighter pressure to reduce medication errors.

Why it matters: - E-prescribing platforms are becoming a core part of digital medication management as healthcare systems try to cut errors, speed up workflows and improve patient safety. - The market’s projected jump to $12.02 billion by 2030 signals sustained demand for software that connects prescribers, pharmacies and patient records. - The growth outlook also points to expanding spending on healthcare IT infrastructure and compliance tools.

What happened: - The Business Research Company released its E-Prescribing Platforms Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report estimates the market was worth $3.83 billion in 2025 and will reach $4.8 billion in 2026. - The report projects the market will grow to $12.02 billion by 2030 at a 25.8% CAGR. - The company said the report reflects demand from digital health modernization across global healthcare systems. - More information is available in the free sample report and the full report.

The details: - E-prescribing platforms let healthcare professionals create, send and manage prescriptions electronically. - The systems are designed to reduce manual errors and improve communication between prescribers and pharmacies. - The platforms can check for drug interactions, allergies and dosage mistakes before a prescription is sent. - Market growth in the near term is tied to rising electronic health record adoption, stricter rules on digital prescriptions, better healthcare IT systems and demand for more efficient workflows. - Longer-term growth is tied to cloud-based and hybrid e-prescribing systems, AI-powered clinical decision support, real-time prescription monitoring, telemedicine and patient safety requirements. - The report identifies cloud adoption, pharmacy management integration, stronger medication safety measures, telehealth expansion and increased regulatory oversight as key trends. - EHR adoption is a major demand driver because e-prescribing tools integrate with patient records to streamline prescription management. - In July 2024, the European Commission said average access to electronic health records through online portals across the EU reached 79%, up from 72% in 2022. - North America held the largest share of the e-prescribing platforms market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests e-prescribing is moving from a point solution to a more integrated layer inside broader digital health systems. - The emphasis on AI decision support and real-time monitoring shows the market is shifting toward prevention and oversight, not just electronic transmission of prescriptions. - Stronger regulation is acting as both a constraint and a growth driver by pushing providers toward compliant digital workflows.

What’s next: - The market will likely continue to gain from telemedicine growth and wider cloud deployment. - Vendors will probably compete more on workflow integration, medication safety features and regulatory readiness. - Regional growth outside North America may accelerate as EHR adoption expands and digital health infrastructure improves. - The Business Research Company is also promoting related reports on genomic urine testing, ocular genetic diagnostics and live attenuated polio vaccines.

The bottom line: - E-prescribing platforms are set for rapid expansion as healthcare providers push deeper into digital prescribing, safer medication management and connected clinical workflows.